Year |
Citation |
Score |
2016 |
Ueberberg S, Tannapfel A, Schenker P, Viebahn R, Uhl W, Schneider S, Meier JJ. Differential expression of cell-cycle regulators in human beta-cells derived from insulinoma tissue. Metabolism: Clinical and Experimental. 65: 736-46. PMID 27085780 DOI: 10.1016/J.Metabol.2016.02.007 |
0.343 |
|
2013 |
Balla DZ, Gottschalk S, Shajan G, Ueberberg S, Schneider S, Hardtke-Wolenski M, Jaeckel E, Hoerr V, Faber C, Scheffler K, Pohmann R, Engelmann J. In vivo visualization of single native pancreatic islets in the mouse. Contrast Media & Molecular Imaging. 8: 495-504. PMID 24375905 DOI: 10.1002/Cmmi.1580 |
0.339 |
|
2011 |
Schneider S, Klein HH. Long-term graft function of cryostored alginate encapsulated rat islets. European Journal of Medical Research. 16: 396-400. PMID 22024439 DOI: 10.1186/2047-783X-16-9-396 |
0.57 |
|
2011 |
Ueberberg S, Deutschbein T, Klein HH, Dietrich JW, Akinturk S, Prochnow N, Schirrmacher R, Schneider S. Protection from diabetes development by single-chain antibody-mediated delivery of a NF-κB inhibitor specifically to β-cells in vivo. American Journal of Physiology. Endocrinology and Metabolism. 301: E83-90. PMID 21521716 DOI: 10.1152/Ajpendo.00603.2010 |
0.566 |
|
2011 |
Meier JJ, Ueberberg S, Korbas S, Schneider S. Diminished glucagon suppression after β-cell reduction is due to impaired α-cell function rather than an expansion of α-cell mass. American Journal of Physiology. Endocrinology and Metabolism. 300: E717-23. PMID 21285404 DOI: 10.1152/Ajpendo.00315.2010 |
0.368 |
|
2011 |
Schneider S, Klein HH. Preserved insulin secretion capacity and graft function of cryostored encapsulated rat islets. Regulatory Peptides. 166: 135-8. PMID 20959122 DOI: 10.1016/J.Regpep.2010.10.005 |
0.586 |
|
2010 |
Ueberberg S, Ziegler D, Schechinger W, Dietrich JW, Akinturk S, Klein HH, Schneider S. In vitro phage display in a rat beta cell line: a simple approach for the generation of a single-chain antibody targeting a novel beta cell-specific epitope. Diabetologia. 53: 1384-94. PMID 20369222 DOI: 10.1007/S00125-010-1725-9 |
0.56 |
|
2009 |
Ueberberg S, Schneider S. Phage library-screening: a powerful approach for generation of targeting-agents specific for normal pancreatic islet-cells and islet-cell carcinoma in vivo. Regulatory Peptides. 160: 1-8. PMID 19958795 DOI: 10.1016/J.Regpep.2009.11.017 |
0.407 |
|
2009 |
Ueberberg S, Meier JJ, Waengler C, Schechinger W, Dietrich JW, Tannapfel A, Schmitz I, Schirrmacher R, Köller M, Klein HH, Schneider S. Generation of novel single-chain antibodies by phage-display technology to direct imaging agents highly selective to pancreatic beta- or alpha-cells in vivo. Diabetes. 58: 2324-34. PMID 19592622 DOI: 10.2337/Db09-0658 |
0.584 |
|
2009 |
Schneider S, Virostko J, Reimann A, Powers A. Recent Efforts to Develop Imaging Methods and β -Cell-Specific Contrast Agents for Non-Invasive in vivo Assessment of β-Cell Mass Recent Patents On Endocrine, Metabolic & Immune Drug Discovery. 3: 157-161. DOI: 10.2174/187221409789104737 |
0.367 |
|
2007 |
Schneider S, Ueberberg S, Korobeynikov A, Schechinger W, Schwanstecher C, Schwanstecher M, Klein HH, Schirrmacher E. Synthesis and evaluation of a glibenclamide glucose-conjugate: a potential new lead compound for substituted glibenclamide derivatives as islet imaging agents. Regulatory Peptides. 139: 122-7. PMID 17222470 DOI: 10.1055/S-2007-972443 |
0.562 |
|
2006 |
Roggenland D, Schneider S, Klein HH, Kann PH. [Endosonography -- an additional diagnostic possibility in the differentiation between the two common types of primary hyperaldosteronism]. Medizinische Klinik (Munich, Germany : 1983). 101: 65-8. PMID 16418816 DOI: 10.1007/S00063-006-1009-9 |
0.489 |
|
2006 |
Zimmermann H, Katsen-Globa A, Ehrhart F, Reuss R, Feilen PJ, Sukhorukov VL, Schneider S, Weber MM, Zimmermann U. 102. Improved cryopreservation of pancreatic islets and multicellular spheroids in IBMT-miniaturized cryosubstrates Cryobiology. 53: 411. DOI: 10.1016/J.Cryobiol.2006.10.103 |
0.323 |
|
2005 |
Schneider S, Klein HH. Inosine improves islet xenograft survival in immunocompetent diabetic mice. European Journal of Medical Research. 10: 283-6. PMID 16055398 |
0.521 |
|
2005 |
Schneider S, Feilen PJ, Schreckenberger M, Schwanstecher M, Schwanstecher C, Buchholz HG, Thews O, Oberholzer K, Korobeynikov A, Bauman A, Comagic S, Piel M, Schirrmacher E, Shiue CY, Alavi AA, et al. In vitro and in vivo evaluation of novel glibenclamide derivatives as imaging agents for the non-invasive assessment of the pancreatic islet cell mass in animals and humans. Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [and] German Diabetes Association. 113: 388-95. PMID 16025400 DOI: 10.1055/s-2005-865711 |
0.554 |
|
2004 |
Schneider S, Schirrmacher E, Schreckenberger M, Schwanstecher M, Feilen P, Bucholz H, Thews O, Oberholzer K, Shiue C, Alavi A, Rösch F, Schirrmacher R, Weber M. In-vitro and in-vivo evaluation of [18F]fluorethoxy-bromo-glibenclamide for the non invasive visualisation of the pancreatic islet cell mass in humans using PET Experimental and Clinical Endocrinology & Diabetes. 112. DOI: 10.1055/S-2004-819252 |
0.371 |
|
Show low-probability matches. |